Literature DB >> 30772444

Twenty-Five Year Trends in the Incidence of Ductal Carcinoma in Situ in US Women.

Tawakalitu O Oseni1, Biqi Zhang2, Suzanne B Coopey2, Michele A Gadd2, Kevin S Hughes2, David C Chang3.   

Abstract

BACKGROUND: The rising incidence of ductal carcinoma in situ (DCIS) since the widespread enactment of mammography screening has been well documented. Patterns in DCIS incidence among women of various ages and across different racial and ethnic groups have not been well described. STUDY
DESIGN: The Surveillance, Epidemiology, and End Results public-use data set was queried for all women aged 40 years and older diagnosed with DCIS between 1990 and 2014. Annual age-adjusted incidence rates were compared among white, black, Hispanic, and Asian-Pacific Islander women. Additionally, using mammography screening data obtained from the CDC, patterns in mammography screening over time and as they relate to DCIS incidence rates by race and ethnicity were evaluated.
RESULTS: We identified 200,400 women aged 40 years or older with DCIS. Between 1998 and 2014, a period that saw flux in national breast screening guidelines, DCIS incidence rates increased in blacks, Hispanics, and Asian-Pacific Islanders, but remained relatively unchanged in whites (increase in number of DCIS diagnoses per 100,000 individuals in the population per year among blacks +0.66/p < 0.01, Hispanics +3.0/p < 0.01, Asian-Pacific Islanders +0.53/p < 0.01, and whites +0.07/p = 0.21). After accounting for age, year of diagnosis, and mammography screening rates, DCIS incidence was found to be similar between white and black women (0.8 fewer diagnoses per 100,000 individuals compared with whites; p = 0.36) but lower for Hispanic women (9.7 fewer diagnoses per 100,000 individuals compared with whites; p < 0.01).
CONCLUSIONS: The DCIS incidence rates are influenced substantially by breast cancer mammography screening patterns. However, differences exist by race and ethnicity and are not fully explained by screening mammography trends alone. Consideration should be given to including race and ethnicity in determining optimal breast screening guidelines.
Copyright © 2019 American College of Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2019        PMID: 30772444     DOI: 10.1016/j.jamcollsurg.2019.01.018

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  7 in total

1.  Is conservative management of ductal carcinoma in situ risky?

Authors:  Lan Zheng; Yesim Gökmen-Polar; Sunil S Badve
Journal:  NPJ Breast Cancer       Date:  2022-04-28

2.  Chronological Trends of Breast Ductal Carcinoma In Situ: Clinical, Radiologic, and Pathologic Perspectives.

Authors:  Si Eun Lee; Ha Yan Kim; Jung Hyun Yoon; Eun-Kyung Kim; Jee Ye Kim; Min Jung Kim; Ga Ram Kim; Youngjean Vivian Park; Hee Jung Moon
Journal:  Ann Surg Oncol       Date:  2021-07-01       Impact factor: 5.344

3.  Prognostic Score-Based Stratification Analysis Reveals Universal Benefits of Radiotherapy on Lowering the Risk of Ipsilateral Breast Event for Ductal Carcinoma In Situ Patients with Different Risk Levels.

Authors:  Libo Yang; Dongli Lu; Yutian Lai; Mengjia Shen; Qiuxiao Yu; Ting Lei; Tianjie Pu; Hong Bu
Journal:  Ann Surg Oncol       Date:  2020-08-13       Impact factor: 5.344

4.  Molecular signatures of in situ to invasive progression for basal-like breast cancers: An integrated mouse model and human DCIS study.

Authors:  Aatish Thennavan; Susana Garcia-Recio; Siyao Liu; Xiaping He; Charles M Perou
Journal:  NPJ Breast Cancer       Date:  2022-07-18

5.  An insight into the invasion of breast ductal carcinoma in situ based on clinical, pathological and hematological data.

Authors:  Yanbiao Liu; Zining Jin; Xinmiao Yu; Ang Zheng; Feng Jin; Xu Wang
Journal:  PeerJ       Date:  2022-08-31       Impact factor: 3.061

Review 6.  Reflecting on 20 years of breast cancer modeling in CISNET: Recommendations for future cancer systems modeling efforts.

Authors:  Amy Trentham-Dietz; Oguzhan Alagoz; Christina Chapman; Xuelin Huang; Jinani Jayasekera; Nicolien T van Ravesteyn; Sandra J Lee; Clyde B Schechter; Jennifer M Yeh; Sylvia K Plevritis; Jeanne S Mandelblatt
Journal:  PLoS Comput Biol       Date:  2021-06-17       Impact factor: 4.475

7.  Modeling the natural history of ductal carcinoma in situ based on population data.

Authors:  Sarocha Chootipongchaivat; Nicolien T van Ravesteyn; Xiaoxue Li; Hui Huang; Harald Weedon-Fekjær; Marc D Ryser; Donald L Weaver; Elizabeth S Burnside; Brandy M Heckman-Stoddard; Harry J de Koning; Sandra J Lee
Journal:  Breast Cancer Res       Date:  2020-05-27       Impact factor: 6.466

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.